Peter de Nully Brown

Peter de Nully Brown

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


  1. Published

    Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma

    Biccler, J. L., Savage, K. J., Brown, Peter de Nully, Jørgensen, J., Larsen, T. S., Poulsen, C. B., Stoltenberg, D., Sehn, L. H., Scott, D. W., Gerrie, A. S., Jakobsen, L. H., Bøgsted, M., El-galaly, T. C. & Villa, D., 2019, In: Leukemia and Lymphoma. 60, 10, p. 2516-2523

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study

    Maksten, E. F., Jakobsen, L. H., Modrau, B., Jensvoll, H., Kragholm, K. H., Jørgensen, J. M., Clausen, M. R., Pedersen, R. S., Dessau-Arp, A., Larsen, T. S., Poulsen, Christian Bjørn, Gang, Anne Ortved, Brown, Peter de Nully, El-Galaly, T. C. & Severinsen, M. T., 2024, In: Journal of Geriatric Oncology. 15, 1, 9 p., 101672.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy

    Baech, J., Severinsen, M. T., Øvlisen, A. K., Frederiksen, H., Vestergaard, P., Torp-Pedersen, Christian, Jørgensen, J., Clausen, M. R., Poulsen, Christian Bjørn, Brown, Peter de Nully, Gang, Anne Ortved, Pedersen, R. S., Smedby, K. E., Eloranta, S., Jakobsen, L. H. & El-Galaly, T. C., 2022, In: Blood advances. 6, 15, p. 4427-4435

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    S-phase induction by interleukin-6 followed by chemotherapy in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphoma

    Brown, Peter de Nully, Diamant, M., Jensen, Peter Østrup, Geisler, C. H., Mortensen, B. T. & Nissen, N. I., Jul 1999, In: Leukemia and Lymphoma. 34, 3-4, p. 325-33 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

    Nowakowski, G. S., Willenbacher, W., Greil, R., Larsen, T. S., Patel, K., Jäger, U., Manges, R. F., Trümper, L., Everaus, H., Kalakonda, N., Brown, Peter de Nully, Jørgensen, J. M., Cunningham, D., Dell’Aringa, J., Fox, B., Rubio, N. D., Kilavuz, N., Casadebaig, M. L., Manzke, O. & Munoz, J., 2022, In: International Journal of Hematology. 115, 2, p. 222-232

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort study

    Trab, Trine, Baech, J., Jakobsen, L. H., Husby, S., Severinsen, M. T., Eloranta, S., Gørløv, J. S., Jørgensen, J. M., Gudbrandsdottir, S., Larsen, T. S., Brown, Peter de Nully, Grønbæk, Kirsten, Smedby, K. E. & El-Galaly, T. C., 2023, In: The Lancet Haematology. 10, 10, p. e838-e848 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Serine protease immunohistochemistry and lectin histochemistry in the small intestine of weaned and unweaned pigs

    Brown, Peter de Nully, Poulsen, Steen Seier & Wells, M., Jan 1991, In: Research in Veterinary Science. 50, 1, p. 1-5 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Sexual dysfunction is highly prevalent in male survivors of malignant lymphoma

    Micas Pedersen, S., Nielsen, T. H., Gang, Anne Ortved, Poulsen, Christian Bjørn, Brown, Peter de Nully, Jørgensen, N., Feltoft, C. L. & Pedersen, Lars Møller, 2023, In: Sexual Medicine. 11, 2, 10 p., qfad021.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

    Zucca, E., Rondeau, S., Vanazzi, A., Østenstad, B., Mey, U. J. M., Rauch, D., Wahlin, B. E., Hitz, F., Hernberg, M., Johansson, A-S., Brown, P. D. N., Hagberg, H., Ferreri, A. J. M., Lohri, A., Novak, U., Zander, T., Bersvendsen, H., Bargetzi, M., Mingrone, W., Krasniqi, F. & 7 others, Dirnhofer, S., Hayoz, S., Hawle, H., Vilei, S. B., Ghielmini, M., Kimby, E. & Swiss Group for Clinical Cancer Research and the Nordic Lymphoma Group, S. G. F. C. C. R. A. T. N. L. G., 2019, In: Blood. 134, 4, p. 353-362 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI

    Biccler, J., Eloranta, S., Brown, Peter de Nully, Frederiksen, H., Jerkeman, M., Smedby, K. E., Bøgsted, M. & El-Galaly, T. C., Jan 2018, In: Cancer Medicine. 7, 1, p. 114-122 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...3 4 5 6 7 8 9 Next

ID: 165119349